Find participating medical centers and current study status in each of them

    Find participating medical centers

    A study to assess whether people with early or locally advanced/inflammatory HER2-positive breast cancer prefer to receive combined pertuzumab and trastuzumab treatment at home or in a hospital setting

    A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

    • Cancer
    • Breast Cancer
    • Inflammatory Breast Cancer
    • Locally Advanced Breast Cancer
    • Breast Cancer HER-2 Positive
    • Early Breast Cancer
    • HER2-Positive Breast Cancer

    For the latest version of this information please go to www.forpatients.roche.com